Feed VREX
VR

Varex Imaging Corporation VREX NASDAQ · Healthcare · United States

$18.13 +0.17% +$0.03

Summary

39 / 100 · Bulios Score

What speaks for it

  • It beat profit estimates 7 times in the last 8 quarters.

What to watch

  • Revenue fell by 0.6% a year over the last 3 years.
  • You pay 34.8 USD for 1 USD of yearly profit, a lot for its sector.
  • It reports a profit, yet spends more cash than it brings in.
  • Operating profit covers the interest on its debt only 1.7 times.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Fair Value Price today $18.13

By our assumptions the price matches the value of the business: the two differ by less than 10 %.

P/E today 34.8 9.2% lower
5-year average P/E 38.4
P/E today 34.8
Medical - Devices industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 34.8 USD for 1 USD of yearly profit. Over the last five years it was 38.4 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 2.7% a year over 5 years. Over the last 3 years it fell by 0.6% a year.

Growth in detail

Does it make money?

Poorly

Where 100 USD of revenue goes

Net profit, industry median (Medical - Devices) 6.9 USD

Out of every 100 USD of revenue, 2.6 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Neutral

Today's price within the analysts' price targets

The average target of $14.5 is 20% below today's price. 29% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2024

By product

By region

Medical Segment brings in 72% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy